Benjamin Kleinstiver
Impact in
- Business and International Management top 0.05%
- Innovation and Socioeconomic Development
- Aging top 0.2%
Papers in
-
- CRISPR and Genetic Engineering 63
- RNA and protein synthesis mechanisms 25
- Advanced biosensing and bioanalysis techniques 22
- RNA regulation and disease 11
- Pluripotent Stem Cells Research 7
- Genetics 15
- Bacterial Genetics and Biotechnology 5
- Co-authors
- J. Keith Joung (22 shared papers)Shengdar Q. Tsai (10 shared papers)Michelle S. Prew (8 shared papers)Nathalie T. Nguyen (5 shared papers)Zongli Zheng (4 shared papers)Vikram Pattanayak (2 shared papers)Russell T. Walton (5 shared papers)Kathleen A. Christie (6 shared papers)
- Journals
- Nature (9 papers)Nature Biotechnology (8 papers)Nature Communications (6 papers)Molecular Therapy (5 papers)Nature Biomedical Engineering (4 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Benjamin Kleinstiver
86 papers receiving 10.7k citations
Benjamin Kleinstiver's Hit Papers
Peers
Comparison fields: 5 of 131
- Business and International Management 1.1k
- Aging 716
- Molecular Biology 9.7k
- Genetics 2.1k
- Insect Science 754
Countries citing papers authored by Benjamin Kleinstiver
This map shows the geographic impact of Benjamin Kleinstiver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Kleinstiver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Kleinstiver more than expected).
Fields of papers citing papers by Benjamin Kleinstiver
This network shows the impact of papers produced by Benjamin Kleinstiver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Kleinstiver. The network helps show where Benjamin Kleinstiver may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Kleinstiver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects Hit paper breakdown → | 2016 | 2189 |
| 2 | Engineered CRISPR-Cas9 nucleases with altered PAM specificities Hit paper breakdown → | 2015 | 1376 |
| 3 | Enhanced proofreading governs CRISPR–Cas9 targeting accuracy Hit paper breakdown → | 2017 | 958 |
| 4 | Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants Hit paper breakdown → | 2020 | 934 |
| 5 | Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells Hit paper breakdown → | 2016 | 555 |
| 6 | Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing Hit paper breakdown → | 2019 | 531 |
| 7 | Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition Hit paper breakdown → | 2015 | 504 |
| 8 | High levels of AAV vector integration into CRISPR-induced DNA breaks Hit paper breakdown → | 2019 | 344 |
| 9 | Astrocytic interleukin-3 programs microglia and limits Alzheimer’s disease Hit paper breakdown → | 2021 | 272 |
| 10 | 2018 | 265 | |
| 11 | 2018 | 205 | |
| 12 | 2018 | 203 | |
| 13 | 2017 | 177 | |
| 14 | 2019 | 166 | |
| 15 | Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease Hit paper breakdown → | 2025 | 159 |
| 16 | 2018 | 157 | |
| 17 | 2016 | 143 | |
| 18 | 2020 | 129 | |
| 19 | 2018 | 97 | |
| 20 | 2023 | 90 |
About Benjamin Kleinstiver
Benjamin Kleinstiver is a scholar working on Molecular Biology, Genetics, Aging, Business and International Management and Insect Science, having authored 90 papers that have together received 11.0k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (63 papers), RNA and protein synthesis mechanisms (25 papers), Advanced biosensing and bioanalysis techniques (22 papers), RNA regulation and disease (11 papers), Pluripotent Stem Cells Research (7 papers), CAR-T cell therapy research (6 papers), Bacterial Genetics and Biotechnology (5 papers) and Insect symbiosis and bacterial influences (5 papers). The work is most often cited by research in Business and International Management (1.1k citations), Aging (716 citations), Molecular Biology (9.7k citations), Genetics (2.1k citations) and Insect Science (754 citations). Benjamin Kleinstiver has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include J. Keith Joung, Shengdar Q. Tsai, Michelle S. Prew, Nathalie T. Nguyen, Zongli Zheng, Vikram Pattanayak, Russell T. Walton, Kathleen A. Christie, Martin J. Aryee and Madelynn N. Whittaker. Their work appears in journals such as Nature, Nature Biotechnology, Nature Communications, Molecular Therapy and Nature Biomedical Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.